VANCOUVER, BC, and BASEL, SWITZERLAND — Genevant Sciences, a leading nucleic acid delivery company with world- class platforms and a robust and expansive lipid nanoparticle (LNP) patent portfolio, announced the… Read More
PRE-AMP, AMPLITUDE’S VENTURE STUDIO, TO USE EVOTEC’S INDUSTRIALISED DRUG DISCOVERY PLATFORMS TO RAPIDLY IDENTIFY AND VALIDATE LEADING-EDGE SCIENCE, ACCELERATING THE FORMATION OF NEW COMPANIES TO BRING FIRST-IN-CLASS THERAPIES TO PATIENTS… Read More
Dr.Bill, a medical billing platform, offers a streamlined approach to administration, facilitating efficient compensation for family physicians VANCOUVER, BC — As part of its commitment to resolve physician billing issues, Dr.Bill,… Read More
Preliminary data from the first cohort demonstrates that EP-104GI was well tolerated with no drug-related adverse events reported VICTORIA, BC, — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX),… Read More
TORONTO, ON — adMare BioInnovations (adMare) and MaRS Discovery District (MaRS) are pleased to welcome Quthero Canada and NorthMiRs as the first Ontario-based ventures in the MaRS-adMare Therapeutics (Tx) Accelerator…. Read More
